The global metabolic disorders therapeutics market is on a promising growth trajectory, fueled by the increasing prevalence of metabolic disorders and advancements in treatment options. Valued at over USD 70 billion in 2022, the market is projected to reach approximately USD 108 billion by 2028, expanding at a compound annual growth rate (CAGR) of 7% during the forecast period...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian